Pages that link to "Q48308737"

The following pages link to Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse (Q48308737):

Displaying 27 items.

• Effects of exogenous factors on the cerebral glutathione in rodents (Q28318598) (← links)
• Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress (Q30862475) (← links)
• MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease (Q34660052) (← links)
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. (Q35589979) (← links)
• Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7 (Q35740789) (← links)
• Behavioral and Neurochemical Deficits in Aging Rats with Increased Neonatal Iron Intake: Silibinin's Neuroprotection by Maintaining Redox Balance (Q36215968) (← links)
• Oxidative stress as a cause of Parkinson's disease (Q37003217) (← links)
• Geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson's disease (Q37298364) (← links)
• Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP. (Q38664598) (← links)
• Motor Function in MPTP-Treated Tree Shrews (Tupaia belangeri chinensis). (Q42257653) (← links)
• (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease (Q42541023) (← links)
• Effect of acute administration of 1,2,3,4-tetrahydroisoquinoline on the levels of glutathione and reactive oxygen species, and on the enzymatic activity of gamma-glutamyl transpeptidase in dopaminergic structures of rat brain (Q43818793) (← links)
• Protective effect of melatonin in a chronic experimental model of Parkinson's disease (Q44052474) (← links)
• Effects of low selenium diets on antioxidant status and MPTP toxicity in mice (Q44689628) (← links)
• Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease (Q46385532) (← links)
• Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. (Q46552275) (← links)
• Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP( )] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione. (Q46716527) (← links)
• An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo. (Q48197823) (← links)
• Dopaminergic system activity and cellular defense mechanisms in the striatum and striatal synaptosomes of the rat subchronically exposed to manganese. (Q48217310) (← links)
• Increased striatal lipid peroxidation after intracerebroventricular MPP administration to mice (Q48273713) (← links)
• The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice (Q48516412) (← links)
• MPTP Produces Differential Oxidative Stress and Antioxidative Responses in the Nigrostriatal and Mesolimbic Dopaminergic Pathways (Q48561566) (← links)
• Melatonin is protective against MPTP-induced striatal and hippocampal lesions (Q48821346) (← links)
• Changes of metallothionein i ii proteins in the brain after l-methyl-4-phenylpyridinium administration in mice (Q58027874) (← links)
• Model study on the bioreduction of paraquat, MPP , and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity (Q68830483) (← links)
• Metallothionein inducers protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice (Q73042679) (← links)
• MPTP decreases MT-I mRNA in mouse striatum (Q73818775) (← links)